Lgr5 is overexpressed in several human tumors, including esophageal adenocarcinoma [15], gastric cancer [16, 17], colorectal cancer [18–20], hepatocellular carcinoma [10], ovarian cancer [21], and brain cancer [22]. This evidence concerns the gene LGR5 and esophageal adenocarcinoma.